Niox Group PLC
LSE:NIOX
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
58
75.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NIOX stock under the Base Case scenario is 48.247 GBX. Compared to the current market price of 64.188 GBX, Niox Group PLC is Overvalued by 25%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Niox Group PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NIOX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Niox Group PLC
Balance Sheet Decomposition
Niox Group PLC
Current Assets | 34.1m |
Cash & Short-Term Investments | 21.5m |
Receivables | 8.1m |
Other Current Assets | 4.5m |
Non-Current Assets | 53.4m |
PP&E | 1.1m |
Intangibles | 29.7m |
Other Non-Current Assets | 22.6m |
Current Liabilities | 5.4m |
Accounts Payable | 900k |
Accrued Liabilities | 3.4m |
Other Current Liabilities | 1.1m |
Non-Current Liabilities | 300k |
Long-Term Debt | 300k |
Earnings Waterfall
Niox Group PLC
Revenue
|
39m
GBP
|
Cost of Revenue
|
-11m
GBP
|
Gross Profit
|
28m
GBP
|
Operating Expenses
|
-22.2m
GBP
|
Operating Income
|
5.8m
GBP
|
Other Expenses
|
5.9m
GBP
|
Net Income
|
11.7m
GBP
|
Free Cash Flow Analysis
Niox Group PLC
GBP | |
Free Cash Flow | GBP |
NIOX Profitability Score
Profitability Due Diligence
Niox Group PLC's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Niox Group PLC's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
NIOX Solvency Score
Solvency Due Diligence
Niox Group PLC's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Niox Group PLC's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NIOX Price Targets Summary
Niox Group PLC
According to Wall Street analysts, the average 1-year price target for NIOX is 83.028 GBX with a low forecast of 69.69 GBX and a high forecast of 95.55 GBX.
Dividends
Current shareholder yield for NIOX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Circassia Group Plc is a holding company, which engages in the development and commercialization of respiratory products. The company is headquartered in Oxford, Oxfordshire and currently employs 128 full-time employees. The company went IPO on 2014-03-13. The Company’s product NIOX uses patented technology to measure fractional exhaled nitric oxide (FeNO). Its NIOX FeNO measurement and monitoring products are used by physicians around the globe to help improve asthma diagnosis and management. The firm offers NIOX VERO, a point of care device for the accurate measurement of nitric oxide (NO) as a biomarker of airway inflammation to help diagnose and manage asthma. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The firm provides products and services in around 50 countries.
Contact
IPO
Employees
Officers
The intrinsic value of one NIOX stock under the Base Case scenario is 48.247 GBX.
Compared to the current market price of 64.188 GBX, Niox Group PLC is Overvalued by 25%.